SCHEMBL525423

SCHEMBL525423

CCN(CCN(C)C)Cc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.56
ALDH1A1 P00352 1/20 0.56
CALM1 P0DP23 1/20 0.55
CAMKK2 Q96RR4 1/20 0.55
MAOB P27338 4/20 0.53
BCHE P06276 3/20 0.53
ACHE P22303 3/20 0.53
TAAR1 Q96RJ0 1/20 0.52
CNR2 P34972 1/20 0.52
KDM4E B2RXH2 1/20 0.51
CHRM2 P08172 2/20 0.50
ADRA2A P08913 2/20 0.50
DRD1 P21728 2/20 0.50
SLC6A2 P23975 2/20 0.50
SLC6A4 P31645 2/20 0.50
ADRA1A P35348 2/20 0.50
SLC6A3 Q01959 2/20 0.50
KCNH2 Q12809 2/20 0.50
HTR1A P08908 1/20 0.50
CHRM1 P11229 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL524817 0.90 CALM1 (0.65) TSHRALDH1A1CALM1CAMKK2BCHE
SCHEMBL18157879 0.90 CALM1 (0.65) TSHRALDH1A1CALM1CAMKK2BCHE
SCHEMBL22749466 0.90 MAOB (0.57) TSHRALDH1A1MAOBBCHEACHE
SCHEMBL13962686 0.86 CALM1 (0.58) TSHRALDH1A1CALM1CAMKK2BCHE
SCHEMBL7004343 0.86 KDM4E (0.51) TSHRALDH1A1MAOBBCHEACHE
SCHEMBL10039135 0.85 CNR2 (0.57) TSHRALDH1A1MAOBBCHEACHE
SCHEMBL2320722 0.85 CNR2 (0.57) TSHRALDH1A1MAOBBCHEACHE
SCHEMBL13222337 0.84 HRH3 (0.52) ALDH1A1CALM1CAMKK2BCHEACHE
SCHEMBL9324551 0.84 MAOB (0.53) TSHRALDH1A1MAOBBCHEACHE
SCHEMBL9799856 0.83 TSHR (0.74) TSHRALDH1A1MAOBBCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170320835-A1 HIV REPLICATION INHIBITING PYRIMIDINES JANSSEN PHARMACEUTICA NV (BE) 2017-11-09 US disclosed
US-20170121292-A1 HIV REPLICATION INHIBITING PYRIMIDINES JANSSEN PHARMACEUTICA NV (BE) 2017-05-04 US disclosed
US-9580392-B2 HIV replication inhibiting pyrimidines JANSSEN PHARMACEUTICA NV (BE) 2017-02-28 US disclosed
US-9192577-B2 Pharmaceutical compositions comprising a basic drug compound, a surfactant, and a physiologically tolerable water soluble acid JANSSEN PHARMACEUTICA NV (BE) 2015-11-24 US disclosed
EP-2598111-B1 SKIN CARE COMPOSITIONS COMPRISING SUBSTITUTED DIAMINES UNILEVER PLC (GB) 2015-03-25 EP disclosed
EP-2598111-B1 SKIN CARE COMPOSITIONS COMPRISING SUBSTITUTED DIAMINES UNILEVER PLC (GB) 2015-03-25 EP disclosed
US-20140343006-A1 HIV Replication Inhibiting Pyrimidines JANSSEN PHARMACEUTICA NV (NL) 2014-11-20 US disclosed
US-8476251-B2 Skin care compositions comprising substituted diamines CONOPCO, INC. (US) 2013-07-02 US disclosed
US-8476251-B2 Skin care compositions comprising substituted diamines CONOPCO, INC. (US) 2013-07-02 US disclosed
US-8476251-B2 Skin care compositions comprising substituted diamines CONOPCO, INC. (US) 2013-07-02 US disclosed
US-20090062278-A1 5- OR 6-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION JANSSEN SCIENCES IRELAND UC (IE) 2009-03-05 US disclosed
US-20090062278-A1 5- OR 6-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION JANSSEN SCIENCES IRELAND UC (IE) 2009-03-05 US disclosed
US-7482352-B2 Chemical derivatives and their application as antitelomerase agents AVENTIS PHARMA S.A. (FR) 2009-01-27 US disclosed
US-7326703-B2 (1,10B-Dihydro-2-(aminocarbonyl-phenyl)-5H-pyrazolo[1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors TIBOTEC PHARMACEUTICALS LTD (IL) 2008-02-05 US disclosed
US-20070293511-A1 Crf Receptor Antagonists and Methods SB PHARMCO PUERTO RICO INC. AND NEUROCRINE BIOSCIENCES, INC., A CORPORATION 2007-12-20 US disclosed
US-20070248624-A1 (1,10B-Dihydro-2-(Aminocarbonyl-Phenyl)-5h-Pyrazolo[1,5-C][1,3]Benzoxazin-5-Yl)Phenyl Methanone Derivatives as Hiv Viral Replication Inhibitors JANSSEN SCIENCES IRELAND UC (IE) 2007-10-25 US disclosed
US-20070093502-A1 5- Or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication BONFANTI JEAN-FRANCOIS 2007-04-26 US disclosed
US-20070093502-A1 5- Or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication BONFANTI JEAN-FRANCOIS 2007-04-26 US disclosed
US-20070021449-A1 Pyrimidine derivatives for the prevention of hiv infection HEERES JAN 2007-01-25 US disclosed
WO-2005058874-A1 5- OR 6-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION TIBOTEC PHARMACEUTICALS LTD. (IE) 2005-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140343006-A1 HIV Replication Inhibiting Pyrimidines RRM2B, CCNO, RRM2 TSHR 2901/4885ALDH1A1 3445/4885CALM1 4715/4885
US-20170121292-A1 HIV REPLICATION INHIBITING PYRIMIDINES RRM2B, CCNO, RRM2 TSHR 2901/4885ALDH1A1 3445/4885CALM1 4715/4885
US-20070021449-A1 Pyrimidine derivatives for the prevention of hiv infection ADORA2B, CYP1B1, DPYD TSHR 4564/4885ALDH1A1 188/4885CALM1 2865/4885
US-20070293511-A1 Crf Receptor Antagonists and Methods CRHR1, CRHR2, CRH TSHR 194/4885ALDH1A1 1656/4885CALM1 1872/4885
US-20070093502-A1 5- Or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, SUB1, HYOU1 TSHR 2810/4885ALDH1A1 3108/4885CALM1 3011/4885
US-20090062278-A1 5- OR 6-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CYC1, SUB1 TSHR 3819/4885ALDH1A1 2167/4885CALM1 2157/4885
US-20070248624-A1 (1,10B-Dihydro-2-(Aminocarbonyl-Phenyl)-5h-Pyrazolo[1,5-C][1,3]Benzoxazin-5-Yl)Phenyl Methanone Derivatives as Hiv Viral Replication Inhibitors POLRMT, MAVS, DHX15 TSHR 4879/4885ALDH1A1 789/4885CALM1 3990/4885
US-20170320835-A1 HIV REPLICATION INHIBITING PYRIMIDINES RRM2B, CCNO, RRM2 TSHR 2901/4885ALDH1A1 3445/4885CALM1 4715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.